Samit Hirawat
CIK 1781290 · EVP,Chief Med.Offr.,Drug Dev. · last filed 2026-01-29
Samit Hirawat is an EVP,Chief Med.Offr.,Drug Dev. who has filed 15 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for PCRX, was dated Jan 29, 2026. Across all open-market trades the lifetime net is +$402.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $10.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$10.3K
3
15
$402.3K
Holdings By Company
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-29 | PCRX | Grant (A) | — | $0 | EDGAR |
| 2025-04-29 | CELGr | Buy (P) | +4,250 | $202.2K | EDGAR |
| 2025-03-12 | CELGr | Mixed | +15,331 | -$1.01M | EDGAR |
| 2025-02-19 | CELGr | Buy (P) | +1,823 | $100.0K | EDGAR |
| 2024-11-05 | CELGr | Buy (P) | +1,830 | $100.1K | EDGAR |
| 2024-03-12 | CELGr | Mixed | +13,034 | -$734.2K | EDGAR |
| 2023-07-05 | CELGr | Mixed | +4,570 | -$306.1K | EDGAR |
| 2023-03-14 | CELGr | Mixed | +21,383 | -$1.47M | EDGAR |
| 2022-07-05 | CELGr | Mixed | +4,570 | -$367.8K | EDGAR |
| 2022-03-14 | CELGr | Mixed | +4,970 | -$356.1K | EDGAR |